The Next Wave in Wearables

The wearables market has evolved beyond step counting and heart rate monitoring. The global smart wearables market is projected to grow at a CAGR of 15.3% to $283B by 2030, with healthcare applications leading this explosive growth. As these devices become more sophisticated, they're graduating from their roles as passive monitors and are transitioning to active health partners capable of real-time intervention and predictive care.

From smart glasses that detect neurological conditions to devices that can predict health events before they occur, wearable technology is reshaping how we understand and manage our health.

Join us for an engaging discussion with pioneers who are pushing the boundaries of what's possible in wearable health technology:

• Dr. Amy Kruse, general partner & chief investment officer, Satori Neuro
• Rob Milnes, CEO, Sonda and viO HealthTech

These leaders will explore:

• How the convergence of AI, miniaturized sensors and advanced materials is enabling a new generation of wearables to provide actionable insights and real-time interventions
• The role of smart wearables in managing chronic conditions
• Emerging technologies that will transform wearables by 2030
• How these innovations will reshape the patient-provider relationship

Join us for this forward-looking discussion about the technologies that will fundamentally change how we monitor and manage our health.

ABOUT THE PANELISTS

Dr. Amy Kruse

General Partner & Chief Investment Officer, Satori Neuro

Dr. Amy Kruse is the general partner and chief investment officer of Satori Neuro, a new venture fund focused on mental health, neurotechnology and human flourishing on the Satori Capital platform. Amy leverages her decades of experience as a neuroscientist and her prior roles as an operator and a government program manager to discover transformational companies addressing the largest mental health, brain health and wellness challenges and opportunities. She also draws on her expertise to support Satori Neuro’s portfolio companies as they evaluate and overcome scientific and implementation challenges, with a specific emphasis on deploying complex technology into real-world environments.

Prior to leading Satori Neuro, Amy was a general partner at Prime Movers Lab, where she led the fund’s early-stage life sciences investments in human augmentation and longevity. She continues to serve as a board director at several Prime Movers Lab portfolio companies including: Cognixion, Paradromics, Gilgamesh Pharmaceuticals, Attune Neurosciences and Dimension Inx. Additionally, she serves on the board of Satori Neuro portfolio companies TARA Mind, Apollo Neuro, Kindly Human and Motif Neurotech and is a board observer to portfolio companies Feel Therapeutics and Holobiome.

Rob Milnes

CEO at Sonda and viO HealthTech

Rob Milnes has over 30 years experience in D2C and clinical medical devices and digital health technologies. He has run and advised a number of startups and corporate divisions, setting strategy, raising significant finance, bringing novel technology to market, helping set up quality and regulatory systems, developing marketing and setting up sales channels.

He has acted as non-exec chair, director and investor director, as well as worked in hands-on operational CEO roles, in addition to executing successful exits. His sector experience spans in-vitro diagnostic laboratory and point of care testing; cardiology; obstetrics; gynaecology; fertility; general women’s health; EMG, EEG and sleep neurology; dentistry and ophthalmology.

ABOUT THE MODERATOR

Zachary Poll

Ecosystem Principal, VSP

Zachary Poll is the ecosystem principal at VSP, LP at Scrub Capital, angel investor and mentor at Techstars. He previously led U.S. healthcare partnerships at Plug and Play, and did clinical research at the University of Chicago Medicine and Children's Hospital of Philadelphia. He is a graduate of the University of Pennsylvania and the University of Cambridge.

About MATTER

At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 1,000 current and alumni startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.